메뉴 건너뛰기




Volumn 13, Issue 2, 2012, Pages 97-107

Medical treatment of atrial fibrillation

Author keywords

antiarrhythmic drugs; dronedarone; ranolazine; rate control drugs; upstream therapy

Indexed keywords

AMIODARONE; ATENOLOL; BISOPROLOL; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; DRONEDARONE; ESMOLOL; FLECAINIDE; IBUTILIDE; METOPROLOL; PROPAFENONE; QUINIDINE; RANOLAZINE; SOTALOL; VERAPAMIL; VERNAKALANT;

EID: 84856098161     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32834f23e1     Document Type: Review
Times cited : (21)

References (46)
  • 1
    • 33747052359 scopus 로고    scopus 로고
    • Secular trends in incidence of atrial fibrillation in olmsted county minnesota 1980 to 2000 and implications on the projections for future prevalence
    • Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114:119-125.
    • Circulation , vol.2006 , Issue.114 , pp. 119-125
    • Miyasaka, Y.1    Barnes, M.E.2    Gersh, B.J.3
  • 2
    • 0026011647 scopus 로고
    • Mortality and morbidity in patients receiving encainide flecainide or placebo cardiac arrhythmia suppression trial
    • Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324:781-788.
    • (1991) N. Engl. J. Med. , vol.324 , pp. 781-788
    • Echt, D.S.1    Liebson, P.R.2    Mitchell, L.B.3
  • 3
    • 0025542167 scopus 로고
    • Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion a metaanalysis of randomized control trials
    • Coplen SE, Antman EM, Berlin JA, et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A metaanalysis of randomized control trials. Circulation 1990; 82:1106-1116.
    • (1990) Circulation , vol.82 , pp. 1106-1116
    • Coplen, S.E.1    Antman, E.M.2    Berlin, J.A.3
  • 6
    • 45549089895 scopus 로고    scopus 로고
    • Rhythm control versus rate control for atrial fibrillation and heart failure Atrial Fibrillation and congestive heart failure investigators
    • Roy D, Talajic M, Nattel S, et al., Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358:2667-2677.
    • (2008) N. Engl. J. Med. , vol.358 , pp. 2667-2677
    • Roy, D.1    Talajic, M.2    Nattel, S.3
  • 7
    • 1842434297 scopus 로고    scopus 로고
    • Relationships between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
    • DOI 10.1161/01.CIR.0000121736.16643.11
    • Corley SD, Epstein AE, DiMarco JP, et al., AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004; 109:1509-1513. (Pubitemid 38420179)
    • (2004) Circulation , vol.109 , Issue.12 , pp. 1509-1513
    • Epstein, A.E.1
  • 8
    • 84975766080 scopus 로고    scopus 로고
    • American college of cardiology American heart association task force European society of cardiology committee for practice guidelines European heart rhythm association heart rhythm society ACC
    • Fuster V, Rydén LE, Cannom DS, et al., American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8:651-745.
    • Europace , vol.2006 , Issue.8 , pp. 651-745
    • Fuster, V.1    Rydén, L.E.2    Cannom, D.S.3
  • 9
    • 79960579602 scopus 로고    scopus 로고
    • Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation recordaf registry on cardiac rhythm disorders assessing the control of atrial fibrillation
    • Camm AJ, Breithardt G, Crijns H, et al. Real-Life Observations of Clinical Outcomes With Rhythm- and Rate-Control Therapies for Atrial Fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol 2011; 58:493-501.
    • (2011) J. Am. Coll. Cardiol. , vol.58 , pp. 493-501
    • Camm, A.J.1    Breithardt, G.2    Crijns, H.3
  • 10
    • 77956618692 scopus 로고    scopus 로고
    • Heart rate as a risk factor in chronic heart failure shift: The association between heart rate and outcomes in a randomised placebo-controlled trial
    • SHIFT investigators
    • Böhm M, Swedberg K, Komajda M, et al., SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 2010; 376:886-894.
    • (2010) Lancet , vol.376 , pp. 886-894
    • Böhm, M.1    Swedberg, K.2    Komajda, M.3
  • 11
    • 2342588605 scopus 로고    scopus 로고
    • AFFIRM Investigators Relation between achieved heart rate and outcomes in patients with atrial fibrillation from the atrial fibrillation follow-up investigation of rhythm management AFFIRM study
    • Cooper HA, Bloomfield DA, Bush DE, et al., AFFIRM Investigators. Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] study). Am J Cardiol 2004; 93:1247-1253.
    • (2004) Am. J. Cardiol. , vol.93 , pp. 1247-1253
    • Cooper, H.A.1    Bloomfield, D.A.2    Bush, D.E.3
  • 12
    • 33750330036 scopus 로고    scopus 로고
    • Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies
    • DOI 10.1093/europace/eul106
    • Van Gelder IC, Wyse DG, Chandler ML, et al., RACE and AFFIRM Investigators. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. Europace 2006; 8:935-942. (Pubitemid 44614202)
    • (2006) Europace , vol.8 , Issue.11 , pp. 935-942
    • Van Gelder, I.C.1    Wyse, D.G.2    Chandler, M.L.3    Cooper, H.A.4    Olshansky, B.5    Hagens, V.E.6    Crijns, H.J.G.M.7
  • 13
    • 77951033991 scopus 로고    scopus 로고
    • Lenient versus strict rate control in patients with atrial fibrillation
    • RACE ii investigators
    • Van Gelder IC, Groenveld HF, Crijns HJ, et al., RACE II Investigators. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010; 362:1363-1373.
    • (2001) N. Engl. J. Med. , vol.362 , pp. 1363-1373
    • Van Gelder, I.C.1    Groenveld, H.F.2    Crijns, H.J.3
  • 14
    • 77957738116 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the European society of cardiology ESC
    • European Heart Rhythm Association; European Association for Cardio- Thoracic Surgery Camm AJ Kirchhof P Lip GY et al.
    • European Heart Rhythm Association; European Association for Cardio- Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010; 12:1360-1420.
    • (2010) Europace , vol.12 , pp. 1360-1420
  • 15
    • 10644252875 scopus 로고    scopus 로고
    • Prospective randomized study of atrioventricular ablation and mode-switching dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation the PAF study paroxysmal atrial fibrillation
    • Brignole M, Gianfranchi L, Menozzi C, et al. Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation. The PAF study (paroxysmal atrial fibrillation). Europace 1999; 1:15-19.
    • (1999) Europace , vol.1 , pp. 15-19
    • Brignole, M.1    Gianfranchi, L.2    Menozzi, C.3
  • 16
    • 0036297481 scopus 로고    scopus 로고
    • An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation
    • DOI 10.1053/euhj.2001.2971
    • Brignole M, Menozzi C, Gasparini M, et al., PAF 2 Study Investigators. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J 2002; 23:892-900. (Pubitemid 34717425)
    • (2002) European Heart Journal , vol.23 , Issue.11 , pp. 892-900
    • Brignole, M.1    Menozzi, C.2    Gasparini, M.3    Bongiorni, M.G.4    Botto, G.L.5    Ometto, R.6    Alboni, P.7    Bruna, C.8    Vincenti, A.9    Verlato, R.10
  • 17
    • 54949104627 scopus 로고    scopus 로고
    • Pulmonaryvein isolation for atrial fibrillation in patients with heart failure
    • PABA-CHF Investigators
    • Khan MN, Jaïs P, Cummings J, et al., PABA-CHF Investigators. Pulmonaryvein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 2008; 359:1778-1785.
    • (2008) N. Engl. J. Med. , vol.359 , pp. 1778-1785
    • Khan, M.N.1    Jaïs, P.2    Cummings, J.3
  • 18
    • 73649169745 scopus 로고
    • Cardioversioń of atrial fibrillation a report on the treatment of 65 episodes in 50 patients
    • Lown B, Perlroth MG, Kaidbey S, Abe T, Harken DE. 'Cardioversioń of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients. N Engl J Med. 1963; 269:325-331.
    • (1963) N. Engl. J. Med. , vol.269 , pp. 325-331
    • Lown, B.1    Perlroth, M.G.2    Kaidbey, S.3    Abe, T.4    Harken, D.E.5
  • 19
    • 78751637313 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation: An analysis of patients undergoing cardioversion
    • Nagarakanti R, Ezekowitz MD, Oldgren J, et al. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion. Circulation 2011; 123:131-136.
    • (2011) Circulation , vol.123 , pp. 131-136
    • Nagarakanti, R.1    Ezekowitz, M.D.2    Oldgren, J.3
  • 23
    • 78651329673 scopus 로고    scopus 로고
    • A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation
    • AVRO Investigators
    • Camm AJ, Capucci A, Hohnloser SH, et al., AVRO Investigators. A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. J Am Coll Cardiol 2011; 57:313-321.
    • (2011) J. Am. Coll. Cardiol. , vol.57 , pp. 313-321
    • Camm, A.J.1    Capucci, A.2    Hohnloser, S.H.3
  • 24
    • 0033611744 scopus 로고    scopus 로고
    • Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: A prospective parallel placebo-controlled multicentre study
    • DOI 10.1016/S0167-5273(98)00363-5, PII S0167527398003635
    • Capucci A, Villani GQ, Aschieri D, Piepoli M. Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study. Int J Cardiol 1999; 68:187-196. (Pubitemid 29083469)
    • (1999) International Journal of Cardiology , vol.68 , Issue.2 , pp. 187-196
    • Capucci, A.1    Villani, G.Q.2    Aschieri, D.3    Piepoli, M.4
  • 26
    • 33846261862 scopus 로고    scopus 로고
    • Guideline development group for the NICE clinical guideline for the management of atrial fibrillation rhythm control and cardioversion
    • Sulke N, Sayers F, Lip GY. Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. Rhythm control and cardioversion. Heart 2007; 93:29-34.
    • (2007) Heart , vol.93 , pp. 29-34
    • Sulke, N.1    Sayers, F.2    Lip, G.Y.3
  • 27
    • 77952604921 scopus 로고    scopus 로고
    • A short-term randomized double-blind parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: The dionysos study
    • Le Heuzey JY, De Ferrari GM, Radzik D, et al. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol 2010; 21:597-605.
    • (2010) J. Cardiovasc Electrophysiol , vol.21 , pp. 597-605
    • Le Heuzey, J.Y.1    De Ferrari, G.M.2    Radzik, D.3
  • 28
    • 17944363568 scopus 로고    scopus 로고
    • Sotalol amiodarone atrial fibrillation efficacy trial safe-t investigators amiodarone versus sotalol for atrial fibrillation
    • Singh BN, Singh SN, Reda DJ, et al., Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 2005; 352:1861-1872.
    • (2005) N. Engl. J. Med. , vol.352 , pp. 1861-1872
    • Singh, B.N.1    Singh, S.N.2    Reda, D.J.3
  • 29
    • 34249046359 scopus 로고    scopus 로고
    • A rate-independent method of assessing QT-RR slope following conversion of atrial fibrillation
    • DOI 10.1111/j.1540-8167.2007.00817.x
    • Darbar D, Hardin B, Harris P, Roden DM. A rate-independent method of assessing QT-RR slope following conversion of atrial fibrillation. J Cardiovasc Electrophysiol 2007; 18:636-641. (Pubitemid 46800515)
    • (2007) Journal of Cardiovascular Electrophysiology , vol.18 , Issue.6 , pp. 636-641
    • Darbar, D.1    Hardin, B.2    Harris, P.3    Roden, D.M.4
  • 30
    • 75749090779 scopus 로고    scopus 로고
    • ThermoCool AF Trial investigators comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial
    • Wilber DJ, Pappone C, Neuzil P, et al. ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010; 303:333-340.
    • (2010) JAMA , vol.303 , pp. 333-340
    • Wilber, D.J.1    Pappone, C.2    Neuzil, P.3
  • 32
    • 33645729137 scopus 로고    scopus 로고
    • Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: A systematic review of randomized controlled trials
    • Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Bergmann J-F. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. Arch Intern Med 2006; 166:719-728.
    • (2006) Arch. Intern. Med. , vol.166 , pp. 719-728
    • Lafuente-Lafuente, C.1    Mouly, S.2    Longas-Tejero, M.A.3    Bergmann J, F.4
  • 33
    • 0030859887 scopus 로고    scopus 로고
    • The side effect profile of class III antiarrhythmic drugs: Focus on d,l- sotalol
    • PII S002914997007182
    • MacNeil DJ. The side effect profile of class III antiarrhythmic drugs: focus on d,l-sotalol. Am J Cardiol 1997; 80 (8A):90G-98G. (Pubitemid 27469749)
    • (1997) American Journal of Cardiology , vol.80 , Issue.8 A
    • MacNeil, D.J.1
  • 35
    • 79952125413 scopus 로고    scopus 로고
    • Mixed treatment comparison of dronedarone amiodarone sotalol flecainide and propafenone for the management of atrial fibrillation
    • Freemantle N, Lafuente-Lafuente C, Mitchell S, et al. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace 2011; 13:329-345.
    • (2001) Europace , vol.13 , pp. 329-345
    • Freemantle, N.1    Lafuente-Lafuente, C.2    Mitchell, S.3
  • 37
    • 60549097431 scopus 로고    scopus 로고
    • Effect of dronedarone on cardiovascular events in atrial fibrillation
    • ATHENA Investigators
    • Hohnloser SH, Crijns HJ, van Eickels M, et al., ATHENA Investigators. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009; 360:668-678.
    • (2009) N. Engl. J. Med. , vol.360 , pp. 668-678
    • Hohnloser, S.H.1    Crijns, H.J.2    Van Eickels, M.3
  • 39
    • 84855163167 scopus 로고    scopus 로고
    • Dronedarone in high-risk permanent atrial fibrillation
    • The PALLAS Investigators Epub ahead of print]
    • Connolly SJ, Camm AJ, Halperin JL, et al.; the PALLAS Investigators. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 2011. [Epub ahead of print]
    • (2011) N. Engl. J. Med.
    • Connolly, S.J.1    Camm, A.J.2    Halperin, J.L.3
  • 40
    • 0348129532 scopus 로고    scopus 로고
    • Effects of Ranolazine with Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients with Severe Chronic Angina: A Randomized Controlled Trial
    • DOI 10.1001/jama.291.3.309
    • Chaitman BR, Pepine CJ, Parker JO, et al., Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA 2004; 291:309-316. (Pubitemid 38101603)
    • (2004) Journal of the American Medical Association , vol.291 , Issue.3 , pp. 309-316
    • Chaitman, B.R.1    Pepine, C.J.2    Parker, J.O.3    Skopal, J.4    Chumakova, G.5    Kuch, J.6    Wang, W.7    Skettino, S.L.8    Wolff, A.A.9
  • 42
    • 80051802104 scopus 로고    scopus 로고
    • Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting
    • Miles RH, Passman R, Murdock DK. Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2011; 108:673-676.
    • (2011) Am. J. Cardiol. , vol.108 , pp. 673-676
    • Miles, R.H.1    Passman, R.2    Murdock, D.K.3
  • 43
    • 35148850168 scopus 로고    scopus 로고
    • Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non-ST-segment-elevation acute coronary syndrome: Results from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial
    • DOI 10.1161/CIRCULATIONAHA.107.724880
    • Scirica BM, Morrow DA, Hod H, et al. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 2007; 116:1647-1652. (Pubitemid 47537839)
    • (2007) Circulation , vol.116 , Issue.15 , pp. 1647-1652
    • Scirica, B.M.1    Morrow, D.A.2    Hod, H.3    Murphy, S.A.4    Belardinelli, L.5    Hedgepeth, C.M.6    Molhoek, P.7    Verheugt, F.W.A.8    Gersh, B.J.9    McCabe, C.H.10    Braunwald, E.11
  • 44
    • 44649145463 scopus 로고    scopus 로고
    • Anti-arrhythmic drug therapy for atrial fibrillation: Current anti-arrhythmic drugs, investigational agents, and innovative approaches
    • DOI 10.1093/europace/eun130
    • Savelieva I, Camm J. Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. Europace 2008; 10:647-665. (Pubitemid 351775283)
    • (2008) Europace , vol.10 , Issue.6 , pp. 647-665
    • Savelieva, I.1    Camm, J.2
  • 45
    • 79952217693 scopus 로고    scopus 로고
    • Upstream therapies for management of atrial fibrillation: Review of clinical evidence and implications for European society of cardiology guidelines part I: Primary prevention
    • Savelieva I, Kakouros N, Kourliouros A, Camm AJ. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: Primary prevention. Europace 2011; 13:308-328.
    • (2011) Europace , vol.13 , pp. 308-328
    • Savelieva, I.1    Kakouros, N.2    Kourliouros, A.3    Camm, A.J.4
  • 46
    • 79952217450 scopus 로고    scopus 로고
    • Upstream therapies for management of atrial fibrillation: Review of clinical evidence and implications for European society of cardiology guidelines part II: Secondary prevention
    • Savelieva I, Kakouros N, Kourliouros A, Camm AJ. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: Secondary prevention. Europace 2011; 13:610-625.
    • (2001) Europace , vol.13 , pp. 610-625
    • Savelieva, I.1    Kakouros, N.2    Kourliouros, A.3    Camm, A.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.